Regorafenib (Stivarga®) for heavily pretreated patients with metastatic colorectal cancer (mCRC)
08.10.2025
Regorafenib (Stivarga®) for heavily pretreated patients with metastatic colorectal cancer (mCRC)
08.10.2025
Regorafenib (Stivarga®) for heavily pretreated patients with metastatic colorectal cancer (mCRC)